127 related articles for article (PubMed ID: 32043384)
1. Follicular lymphoma treatment patterns between 2000 and 2014: a SEER-Medicare analysis of elderly patients.
Albarmawi H; Nagarajan M; Onukwugha E; Gandhi AB; Keating KN; Appukkuttan S; Yared J
Future Oncol; 2020 Mar; 16(8):353-365. PubMed ID: 32043384
[No Abstract] [Full Text] [Related]
2. Assessing the Effectiveness of Treatment Sequences for Older Patients With High-risk Follicular Lymphoma With a Multistate Model.
Çağlayan Ç; Terawaki H; Ayer T; Goldstein JS; Rai A; Chen Q; Flowers C
Clin Lymphoma Myeloma Leuk; 2019 May; 19(5):300-309.e5. PubMed ID: 30686772
[TBL] [Abstract][Full Text] [Related]
3. Rituximab for the first-line treatment of stage III-IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation.
Papaioannou D; Rafia R; Rathbone J; Stevenson M; Buckley Woods H; Stevens J
Health Technol Assess; 2012; 16(37):1-253, iii-iv. PubMed ID: 23021127
[TBL] [Abstract][Full Text] [Related]
4. Disparate survival outcomes after front-line chemoimmunotherapy in older patients with follicular, nodal marginal zone and small lymphocytic lymphoma.
Olszewski AJ; Shafqat H; Ali S
Leuk Lymphoma; 2015 Apr; 56(4):942-50. PubMed ID: 24956144
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Sequence of Therapy for Older Patients With Follicular Lymphoma: SEER-Medicare Analysis.
Xie C; Li R; Huang X; Chihara D; Flowers CR
Clin Lymphoma Myeloma Leuk; 2022 Oct; 22(10):e938-e946. PubMed ID: 35871217
[TBL] [Abstract][Full Text] [Related]
6. Treatment Patterns of Follicular Lymphoma in the United States: A Claims Analysis.
Huntington SF; Appukkuttan S; Wang W; Du Y; Hopson S; Babajanyan S
J Health Econ Outcomes Res; 2022; 9(2):115-122. PubMed ID: 36348725
[No Abstract] [Full Text] [Related]
7. Patient-level Factors Associated With the Initial Management of Older Adults Diagnosed With Follicular Lymphoma: A Surveillance, Epidemiology, and End Results-Medicare Analysis.
Yared J; Gandhi AB; Nagarajan M; Albarmawi H; Keating K; Appukkuttan S; Onukwugha E
Clin Lymphoma Myeloma Leuk; 2020 Apr; 20(4):e184-e194. PubMed ID: 31956071
[TBL] [Abstract][Full Text] [Related]
8. Costs associated with follicular lymphoma among individuals diagnosed with non-Hodgkin lymphoma: a longitudinal analysis using SEER-Medicare data.
Albarmawi H; Nagarajan M; Sun K; Gandhi AB; Yared J; Keating KN; Appukkuttan S; Yaldo A; Gharibo M; Onukwugha E
Leuk Lymphoma; 2020 Jan; 61(1):75-83. PubMed ID: 31389296
[TBL] [Abstract][Full Text] [Related]
9. Disease characteristics, treatment patterns, and outcomes of follicular lymphoma in patients 40 years of age and younger: an analysis from the National Lymphocare Study†.
Casulo C; Day B; Dawson KL; Zhou X; Flowers CR; Farber CM; Hainsworth JD; Cerhan JR; Link BK; Zelenetz AD; Friedberg JW
Ann Oncol; 2015 Nov; 26(11):2311-7. PubMed ID: 26362568
[TBL] [Abstract][Full Text] [Related]
10. Front-line management of non-Hodgkin lymphoma in Australia. Part 1: follicular lymphoma.
Trotman J; Cheah CY; Marlton P; Opat S
Intern Med J; 2019 Apr; 49(4):422-433. PubMed ID: 30230156
[TBL] [Abstract][Full Text] [Related]
11. Patterns of delivery of chemoimmunotherapy to patients with follicular lymphoma in the United States: results of the National LymphoCare Study.
Martin P; Byrtek M; Dawson K; Ziemiecki R; Friedberg JW; Cerhan JR; Flowers CR; Link BK
Cancer; 2013 Dec; 119(23):4129-36. PubMed ID: 24006156
[TBL] [Abstract][Full Text] [Related]
12. Follicular lymphoma in the United States: first report of the national LymphoCare study.
Friedberg JW; Taylor MD; Cerhan JR; Flowers CR; Dillon H; Farber CM; Rogers ES; Hainsworth JD; Wong EK; Vose JM; Zelenetz AD; Link BK
J Clin Oncol; 2009 Mar; 27(8):1202-8. PubMed ID: 19204203
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of Follicular Lymphoma.
Cerhan JR
Hematol Oncol Clin North Am; 2020 Aug; 34(4):631-646. PubMed ID: 32586570
[TBL] [Abstract][Full Text] [Related]
14. [Curative effect analysis of rituximab combined with intensive chemotherapy for follicular lymphoma patients with bone marrow involvement].
Xiong W; Yi S; Li H; Liu H; Li Z; Lü R; Liu W; Zou D; Qiu L
Zhonghua Yi Xue Za Zhi; 2015 Nov; 95(44):3593-7. PubMed ID: 26813371
[TBL] [Abstract][Full Text] [Related]
15. Economic evaluation of sequential treatments for follicular non-hodgkin lymphoma.
Soini EJ; Martikainen JA; Vihervaara V; Mustonen K; Nousiainen T
Clin Ther; 2012 Apr; 34(4):915-925.e2. PubMed ID: 22459623
[TBL] [Abstract][Full Text] [Related]
16. Rituximab plus short-duration chemotherapy as first-line treatment for follicular non-Hodgkin's lymphoma: a phase II trial of the minnie pearl cancer research network.
Hainsworth JD; Litchy S; Morrissey LH; Andrews MB; Grimaldi M; McCarty M; Greco FA
J Clin Oncol; 2005 Mar; 23(7):1500-6. PubMed ID: 15632411
[TBL] [Abstract][Full Text] [Related]
17. Patterns of use and survival outcomes of positron emission tomography for initial staging in elderly follicular lymphoma patients.
Rai A; Nastoupil LJ; Williams JN; Lipscomb J; Ward KC; Howard DH; Lee D; Flowers CR
Leuk Lymphoma; 2017 Jul; 58(7):1570-1580. PubMed ID: 27830968
[TBL] [Abstract][Full Text] [Related]
18. Congestive heart failure in older adults diagnosed with follicular lymphoma: A population-based study.
Kenzik KM; Mehta A; Richman JS; Kilgore M; Bhatia S
Cancer; 2018 Nov; 124(21):4221-4230. PubMed ID: 30303522
[TBL] [Abstract][Full Text] [Related]
19. Survival benefit associated with treating follicular lymphoma in patients 80 years or older.
Albarmawi H; Onukwugha E; Keating KN; Appukkuttan S; Yared J
J Geriatr Oncol; 2020 Jan; 11(1):55-61. PubMed ID: 31706831
[TBL] [Abstract][Full Text] [Related]
20. Temporal trends in treatment and survival of older adult diffuse large B-Cell lymphoma patients in the SEER-Medicare linked database.
Shaw J; Harvey C; Richards C; Kim C
Leuk Lymphoma; 2019 Dec; 60(13):3235-3243. PubMed ID: 31185769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
